D-1726-2019 Class II Terminated
FDA drug recall D-1726-2019 was initiated by US Pharmaceuticals Inc. on Jul 11, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process. The recall status is terminated (terminated Jun 25, 2020). Affected quantity: 5017 cases.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2019
- Initiation Date
- Jul 11, 2019
- Termination Date
- Jun 25, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5017 cases
Product description
CVS Therapeutic Menthol Gel, 8 FL OZ (227 g) Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 48136 3
Reason for recall
CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot #'s 28L17, 31L17, 36L17, 40L17, 44L17 EXP 09/2019; 05M17, 09M17, 12M17, 13M17, 23M17 EXP 10/2019; 69P17, 72P17 EXP 11/2019; 42S17, 46S17 EXP 12/2019; 85C18, 86C18 EXP 03/2020; 31J18, 43J18, 55J18, 58J18, 18L18 EXP 07/2020.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1726-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026